Literature DB >> 19386782

Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia.

Tim Waterboer1, Rachel Neale2, Kristina M Michael1, Peter Sehr1, Maurits N C de Koning3,4, Sönke J Weißenborn5, Francesca Sampogna6, Damiano Abeni6, Adele C Green2, Jan Nico Bouwes Bavinck7, Michael Pawlita1.   

Abstract

Solar UV radiation is the main risk factor for cutaneous squamous cell carcinoma (SCC), but infections with skin human papillomavirus (HPV) types have also been linked to the development of SCC. Little is known about the natural history of these infections and whether the seroprevalence of skin HPV types is affected by ambient or individual levels of sun exposure. This study investigated this by analysing sera for antibodies to 26 skin HPV types from five phylogenetic genera obtained from 807 healthy individuals from the Netherlands, Italy and Australia, countries with strong differences in sunlight intensity. Overall HPV seroprevalence was similar across the three countries (50-57 % for beta-HPV types, 40-48 % for gamma-HPV types), and the most frequent beta-HPV and gamma-HPV types were the same in all countries. The highest seroprevalences for 24 of the 26 skin HPV types were observed in Italy (14 types) and Australia (ten types). Seroprevalence among men was generally higher than among women, and the male sex was significantly associated with both beta-HPV [odds ratio (OR) 2.81, 95 % confidence interval (CI) 1.64-4.82] and gamma-HPV (OR 2.42, 95 % CI 1.40-4.18) antibodies in Australia. The only measure of sun sensitivity or UV exposure significantly associated with skin HPV seroprevalence was found for weekend sun exposure in Australia and beta-HPV antibodies. It was concluded that type spectra and HPV seroprevalence are similar in countries with different sunlight intensity, and that levels of UV exposure do not play a strong role in the development of skin HPV antibodies in this study population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19386782     DOI: 10.1099/vir.0.010637-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  21 in total

1.  [Clinical algorithm of cutaneous extragenital wart treatment].

Authors:  A Rübben
Journal:  Hautarzt       Date:  2011-01       Impact factor: 0.751

Review 2.  Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global review.

Authors:  Sarah M Tiggelaar; Margaret J Lin; Raphael P Viscidi; Jia Ji; Jennifer S Smith
Journal:  J Adolesc Health       Date:  2012-02       Impact factor: 5.012

3.  Prospective Study of Human Polyomaviruses and Risk of Cutaneous Squamous Cell Carcinoma in the United States.

Authors:  Anala Gossai; Tim Waterboer; Heather H Nelson; Jennifer A Doherty; Angelika Michel; Martina Willhauck-Fleckenstein; Shohreh F Farzan; Brock C Christensen; Anne G Hoen; Ann E Perry; Michael Pawlita; Margaret R Karagas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02-11       Impact factor: 4.254

4.  Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin.

Authors:  Michelle R Iannacone; Tarik Gheit; Tim Waterboer; Anna R Giuliano; Jane L Messina; Neil A Fenske; Basil S Cherpelis; Vernon K Sondak; Richard G Roetzheim; Kristina M Michael; Massimo Tommasino; Michael Pawlita; Dana E Rollison
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-15       Impact factor: 4.254

5.  Analysis of liquid bead microarray antibody assay data for epidemiologic studies of pathogen-cancer associations.

Authors:  Danny V Colombara; James P Hughes; Andrea N Burnett-Hartman; Stephen E Hawes; Denise A Galloway; Stephen M Schwartz; Roberd M Bostick; John D Potter; Lisa E Manhart
Journal:  J Immunol Methods       Date:  2015-06-11       Impact factor: 2.303

Review 6.  Human genetic dissection of papillomavirus-driven diseases: new insight into their pathogenesis.

Authors:  Vivien Béziat
Journal:  Hum Genet       Date:  2020-05-20       Impact factor: 4.132

7.  High-throughput profiling of the humoral immune responses against thirteen human papillomavirus types by proteome microarrays.

Authors:  Martha Luevano; Hans-Ulrich Bernard; Hugo A Barrera-Saldaña; Victor Trevino; Alejandro Garcia-Carranca; Luisa L Villa; Bradley J Monk; Xiaolin Tan; D Huw Davies; Phil L Felgner; Mina Kalantari
Journal:  Virology       Date:  2010-06-15       Impact factor: 3.616

8.  Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: a population-based study.

Authors:  Shohreh F Farzan; Tim Waterboer; Jiang Gui; Heather H Nelson; Zhongze Li; Kristina M Michael; Ann E Perry; Steven K Spencer; Eugene Demidenko; Adele C Green; Michael Pawlita; Margaret R Karagas
Journal:  Int J Cancer       Date:  2013-04-22       Impact factor: 7.396

Review 9.  Cutaneous squamous cell carcinoma and human papillomavirus: is there an association?

Authors:  Bishr Aldabagh; Jorge Gil C Angeles; Adela R Cardones; Sarah T Arron
Journal:  Dermatol Surg       Date:  2012-08-28       Impact factor: 3.398

10.  The seroprevalence of human papillomavirus by immune status and by ethnicity in London.

Authors:  Delphine Casabonne; Tim Waterboer; Kristina M Michael; Michael Pawlita; Liza Mitchell; Robert Newton; Catherine Harwood; Charlotte Proby
Journal:  Infect Agent Cancer       Date:  2009-09-14       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.